1-20 of 119
Pierluigi Porcu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pathobiology and Targeting of CD38 in Cutaneous T-Cell Lymphoma

Colleen Isabelle, Amy Boles, Kathleen McConnell, Robyn Keller, Lara Cheslow, Jonathan Xu, Scott Waldman, Nitin Chakravarti, Pierluigi Porcu, Neda Nikbakht, Anjali Mishra
Journal: Blood
Blood (2023) 142 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2023-189556
Published: 2023
Journal Articles

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

Eric Jacobsen, Dai Maruyama, Pierluigi Porcu, Kensei Tobinai, Pamela B. Allen, Kenji Ishitsuka, Kunihiro Tsukasaki, Shigeru Kusumoto, Francine M. Foss, Nobuhiko Yamauchi, Satoko Morishima, Yoshitaka Imaizumi, Koji Izutsu, Tatyana Feldman, Toyotaka Kawamata, Yasuyuki Kakurai, Hideyuki Yamauchi, Noha Biserna, Ai Inoue, Shinji Tsutsumi, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 303.
https://doi.org/10.1182/blood-2023-172512
Published: 2023
Journal Articles

Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Aditi Shastri, Eric J Feldman, Alexander N Starodub, Tatyana Feldman, Cristina P Rodriguez, Zachary D. Epstein-Peterson, Don A. Stevens, Adam J Olszewski, Auris O Huen, Pierluigi Porcu, John C Reneau, Stefan K. Barta, Enrica Marchi, Ahmad H Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Sean Donohue, Joyoti Dey, Sagar Agarwal, Rahul Karnik, Ashwin Gollerkeri, Jared Gollob, Stephen D Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 3081.
https://doi.org/10.1182/blood-2023-181130
Published: 2023
Journal Articles

Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Larisa J. Geskin, Pablo L. Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Marie Beylot-Barry, Stéphane Dalle, Eric Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S Khodadoust, Maxime Battistella, Alejandro A Gru, Hélène Moins-Teisserenc, Pier Luigi Zinzani, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood
Blood (2023) 142 (Supplement 1): 185.
https://doi.org/10.1182/blood-2023-173806
Published: 2023
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

The Overlap of Skin and Blood T-Cell Clones in Early-Stage Mycosis Fungoides

Daniel Joffe, Lauren Banner, Safiyyah Bhatti, Laura Gleason, Jenna Mandel, Pierluigi Porcu, Neda Nikbakht
Journal: Blood
Blood (2023) 142 (Supplement 1): 4361.
https://doi.org/10.1182/blood-2023-181229
Published: 2023
Journal Articles

Increased Incidence of Melanoma, Prostate, Lung, Bladder, Renal and Thyroid Cancer after Diagnosis of Primary Cutaneous B-Cell Lymphoma: A SEER Database Analysis

Lauren Banner, Thomas Z Rohan, Rachel Zachian, Tyler Gross, Daniel Joffe, Pierluigi Porcu, Neda Nikbakht
Journal: Blood
Blood (2023) 142 (Supplement 1): 4409.
https://doi.org/10.1182/blood-2023-182303
Published: 2023
Journal Articles

A Two-Part Study Evaluating the Combination of Tazemetostat and CPX-351 (Part 1) and Palbociclib with CPX-351 (Part 2) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Gina Keiffer, Bruno Calabretta, Alexander Mazo, Ubaldo Martinez Outschoorn, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Lindsay Wilde, Margaret Kasner
Journal: Blood
Blood (2023) 142 (Supplement 1): 1550.
https://doi.org/10.1182/blood-2023-186671
Published: 2023
Journal Articles

Real-World Evaluation of T-Prolymphocytic Leukemia Outcomes Using the 2019 T-PLL International Study Group Criteria

Zachary Braunstein, Eric McLaughlin, Anjali Mishra, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6213.
https://doi.org/10.1182/blood-2023-184602
Published: 2023
Journal Articles

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

Elizabeth A. Brem, John M. Burke, Mirko Vukcevic, Pia Kloepfer, Kimberly Saverno, Haifaa Abdulhaq, Andrew M Evens, Pierluigi Porcu, Mazyar Shadman, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 6251.
https://doi.org/10.1182/blood-2023-188482
Published: 2023
Journal Articles

A Phase Ib/II Study Evaluating Navitoclax after Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Gina Keiffer, Sara E. Meyer, Christine Eischen, Ubaldo Martinez Outschoorn, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Lindsay Wilde, Margaret Kasner, Neil Palmisiano
Journal: Blood
Blood (2023) 142 (Supplement 1): 1551.
https://doi.org/10.1182/blood-2023-186765
Published: 2023
Journal Articles

Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease

Haley L. Klimaszewski, Christoph Weigel, Selamawit Addissie, Sarah Schlotter, Tounkara Fode, James P. Dugan, Bradley M. Haverkos, Lynda Villagomez, Mark Lustberg, Pierluigi Porcu, Timothy Voorhees, Michael A Caligiuri, Christopher C. Oakes, Ginny Bumgardner, Robert Baiocchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4476.
https://doi.org/10.1182/blood-2023-189618
Published: 2023
Journal Articles

Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

Nicholas Kendsersky, Rebecca Masel, Amman Bhasin, Tingting Zhan, Carol Gung, Mercy George, Frederick Michael Fellin, Allison Zibelli, Avnish Bhatia, Rajan Singla, Michael Ramirez, Andrew E. Chapman, Patrick Mille, Cassandra Thomas, Joanne Filicko-O'Hara, Barbara Pro, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Andres Ferber, Sameh Gaballa, Ubaldo Martinez Outschoorn
Journal: Blood
Blood (2023) 142 (Supplement 1): 3028.
https://doi.org/10.1182/blood-2023-187847
Published: 2023
Journal Articles

Results from a Phase I Trial Using Nivolumab in Combination with Dose Adjusted EPOCH in Newly Diagnosed Peripheral T-Cell Lymphomas

Bradley M. Haverkos, Jasmine Zain, Manali K. Kamdar, Alexander Neuwelt, Eduardo Davila, Xander Bradeen, Steven M. Bair, Jagar Jasem, Emily Berens, Clayton Smith, Diana Abbott, Pierluigi Porcu
Journal: Blood
Blood (2022) 140 (Supplement 1): 2308–2309.
https://doi.org/10.1182/blood-2022-168979
Published: 2022
Journal Articles

Differences in Progression and Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis at Large Urban Medical Centers

Pamela B. Allen, Subir Goyal, Swaminathan P. Iyer, Sai Talluru, Auris Huen, Irl Brian Greenwell, Jane Scribner, Shel Speegle, Tim Niyogusaba, Sunil Rangarajan, Amitkumar Mehta, Colin B. O'Leary, Anne W. Beaven, Jeffrey M. Switchenko, Amy Ayers, Safiyyah Bhatti, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Francine M. Foss, Mary Jo Lechowicz, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 9431–9433.
https://doi.org/10.1182/blood-2022-170921
Published: 2022
Journal Articles

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1481–1484.
https://doi.org/10.1182/blood-2022-160090
Published: 2022
Journal Articles

Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3760–3761.
https://doi.org/10.1182/blood-2022-160239
Published: 2022
Journal Articles

Therapeutic Potential and Role of CD38 in Cutaneous T-Cell Lymphoma Pathogenesis

Colleen Isabelle, Kathleen McConnell, Amy E Boles, Jonathan E Brammer, Robyn Berge, Carla Portocarrero, Nitin Chakravarti, Pierluigi Porcu, Neda Nikbakht, Anjali Mishra
Journal: Blood
Blood (2022) 140 (Supplement 1): 9216–9218.
https://doi.org/10.1182/blood-2022-170550
Published: 2022
Journal Articles

The Impact of Chemotherapy on Phenotype and Function of Non-Malignant T-Cells in Patients with T-Cell Lymphoma

Meryl Colton, Kimberly Jordan, Eduardo Davila, Xander Bradeen, Jasmine Zain, Pierluigi Porcu, Bradley M. Haverkos
Journal: Blood
Blood (2022) 140 (Supplement 1): 11938–11940.
https://doi.org/10.1182/blood-2022-169691
Published: 2022
Journal Articles

Assessment of Concurrent Personal and Family History of Hematologic Malignancies in Patients Referred for Genetic Counseling at Thomas Jefferson University Hospital (TJUH), Sidney Kimmel Cancer Center (SKCC) from 2014-2021

Molly Halloran, Gina Keiffer, Veda Giri, Laura Gross, Lindsay Wilde, Neil Palmisiano, Pierluigi Porcu, Margaret Kasner
Journal: Blood
Blood (2022) 140 (Supplement 1): 11466–11467.
https://doi.org/10.1182/blood-2022-165510
Published: 2022